| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |